Gundogan and colleagues compared PSMA PET and FDG PET for imaging hepatocellular carcinoma (HCC) in 14 patients and demonstrated PSMA-PET to be superior to FDG PET in staging of HCC [80]. This evidence concerns the gene FOLH1 and hepatocellular carcinoma.